Contrariwise, we show that its overexpression in a cohort of carcinomas of the Spanish CRC Epicolon Study [33] identifies patients with less chances of disease recurrence, supporting an anti-metastatic role for IF1. The gene discussed is ATP5IF1; the disease is colorectal carcinoma.